SCHEMBL6652610

SCHEMBL6652610

N#CCCCn1ccnc1Cc1ccc(Cl)cc1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90B1 P14625 5/20 0.38
TRAP1 Q12931 1/20 0.38
CYP2D6 P10635 1/20 0.37
TSHR P16473 1/20 0.37
CYP2C19 P33261 1/20 0.37
HIF1A Q16665 1/20 0.37
PIK3CD O00329 2/20 0.35
ABL1 P00519 2/20 0.35
EGFR P00533 2/20 0.35
HCK P08631 2/20 0.35
SRC P12931 2/20 0.35
KDR P35968 2/20 0.35
PIK3CA P42336 2/20 0.35
PIK3CB P42338 2/20 0.35
MTOR P42345 2/20 0.35
PIK3CG P48736 2/20 0.35
EPHB4 P54760 2/20 0.35
PRKDC P78527 2/20 0.35
KMT2A Q03164 4/20 0.35
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6650314 0.93 HSP90AA1 (0.36) HSP90B1TRAP1CYP2D6TSHRCYP2C19
SCHEMBL6651569 0.84 KMT2A (0.47) HSP90B1CYP2D6TSHRCYP2C19HIF1A
SCHEMBL6648613 0.84 KCNH2 (0.39) HSP90B1CYP2D6TSHRCYP2C19HIF1A
SCHEMBL5705441 0.84 HSP90AA1 (0.36) HSP90B1CYP2D6TSHRCYP2C19HIF1A
SCHEMBL6654254 0.78 TRPM5 (0.37) CYP2D6TSHRCYP2C19HIF1AKMT2A
SCHEMBL6651515 0.75 KMT2A (0.48) CYP2D6TSHRCYP2C19HIF1AKMT2A
SCHEMBL16061241 0.72 CSNK2A1 (0.42) KMT2AKCNH2ALDH1A1CSNK2A1
SCHEMBL6648269 0.71 KMT2A (0.46) CYP2D6TSHRCYP2C19HIF1AKMT2A
SCHEMBL4909447 0.69 MAPT (0.46) HSP90B1TRAP1CYP2D6CYP2C19KMT2A
SCHEMBL586216 0.68 MEN1 (0.42) TSHRCYP2C19HIF1AKMT2AHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1103243-B1 UTILIZATION OF ARYL(OR HETEROARYL)AZOLYLCARBINOL DERIVATIVES FOR THE TREATMENT OF TROUBLES MEDIATED BY AN EXCESS OF SUBSTANCE P ESTEVE LABOR DR (ES) 2004-01-07 EP claimed